• AMPK–SQSTM1 Feedback Enhances Antioxidant Defense in Tumor S

  2026-07-15

  This study reveals a double-positive feedback loop between AMPK and SQSTM1/p62 under metabolic stress, leading to simultaneous activation of AMPK and NFE2L2/NRF2 antioxidant pathways. The findings clarify how tumor cells adapt to metabolic and oxidative challenges, especially in the context of STK11 and KEAP1 mutations, providing new mechanistic insight for therapeutic intervention.

• Indometacin Sodium Enhances Remyelination via Wnt/β-Catenin

  2026-07-15

  Preisner et al. (2015) demonstrate that indometacin, a nonsteroidal anti-inflammatory drug, promotes endogenous remyelination in models of multiple sclerosis by modulating the Wnt/β-catenin pathway and enhancing oligodendrocyte differentiation. These findings highlight a mechanistic bridge between inflammation control and neuroregenerative processes, informing new strategies for CNS repair.

• Parathyroid hormone (1-34) (human): Advancing Bone and Kidne

  2026-07-14

  Parathyroid hormone (1-34) (human) enables high-fidelity modeling of bone metabolism and kidney disease by acting as a potent, well-characterized PTH1R agonist. This guide delivers actionable workflows, troubleshooting insights, and evidence-based applications, grounded in recent mechanistic breakthroughs and robust product data.

• Translational Redox Biology: Rethinking Amplex Red Assays

  2026-07-14

  A thought-leadership perspective on leveraging Amplex Red (10-Acetyl-3,7-dihydroxyphenoxazine) for translational ROS research, integrating mechanistic nuance and practical workflow guidance. This article synthesizes emerging mechanistic data, competitive assay landscape considerations, and strategic recommendations for robust oxidative stress and redox signaling assays, with actionable insight for researchers aiming to advance from bench to bedside.

• Genistein in Mechanotransduction: Cytoskeleton, Signaling, a

  2026-07-13

  Explore Genistein as a selective tyrosine kinase inhibitor and its pivotal role in cytoskeleton-dependent mechanotransduction for cancer chemoprevention. This article delivers a unique integration of recent autophagy findings and advanced protocol insights for precision oncology research.

• PI3K Activation as a Precision Tool in Translational Osteo-B

  2026-07-13

  This thought-leadership article explores how 740 Y-P, a potent and cell-permeable PI 3-kinase activator from APExBIO, empowers translational researchers to dissect and manipulate the PI3K/AKT signaling pathway in models relevant to vesicular trafficking, apoptosis, and neuronal or osteogenic cell survival. Integrating mechanistic insights from autophagy studies in BMSCs under oxidative stress, the piece not only highlights experimental best practices but also critically positions 740 Y-P within the competitive landscape, offering strategic guidance for researchers seeking to bridge basic signaling discoveries with preclinical therapeutic innovation.

• NU7441 (KU-57788): Redefining DNA-PK Inhibition in Translati

  2026-07-12

  This thought-leadership article examines how the highly selective DNA-PK inhibitor NU7441 (KU-57788) from APExBIO is catalyzing advances in DNA repair and oncology research. Integrating mechanistic insight, protocol guidance, and a cross-domain perspective, it bridges foundational discoveries in DNA damage response with translational opportunities in cancer and neurodegeneration, while critically evaluating the competitive landscape and future outlook.

• Native Protein Gel Electrophoresis: Decoding Function with t

  2026-07-10

  Discover how the Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit enables high-resolution native protein gel electrophoresis, preserving biological function for advanced research. This article delves into mechanistic insights, unique workflow parameters, and the translational impact for precision protein science.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–Receptor Bindi

  2026-07-09

  The reference study reveals that naturally occurring angiotensin peptides, including Angiotensin 1/2 (1-6), can enhance SARS-CoV-2 spike protein binding to cellular receptors, particularly AXL, with potential implications for COVID-19 pathogenesis. These findings bridge classic renin-angiotensin system research with emerging infectious disease mechanisms, providing new directions for peptide-based investigation.

• Metabolomics for Rapid Detection of Carbapenemase Resistance

  2026-07-09

  This study pioneers the use of LC-MS/MS metabolomics to distinguish carbapenemase-producing Enterobacterales (CPE) from non-CPE within seven hours, identifying 21 metabolite biomarkers associated with resistance. These findings advance rapid diagnostics for antibiotic resistance and provide mechanistic insights into the metabolic pathways linked to CPE phenotypes.

• Angiotensin 1/2 (1-6): Innovative Pathways in Vascular and V

  2026-07-08

  Explore how Angiotensin 1/2 (1-6) advances renin-angiotensin system research and viral pathogenesis studies. This article reveals new mechanistic insights, practical assay implications, and protocol guidance for cardiovascular and SARS-CoV-2 research.

• Alosetron: 5-HT3 Receptor Antagonist in GI Stem Cell Researc

  2026-07-08

  Alosetron enables precise modulation of the 5-HT3 receptor signaling pathway, unlocking advanced studies of gastrointestinal motility and epithelial polarity. This article details optimized workflows, troubleshooting strategies, and the transformative impact of Alosetron in stem cell and polarity research.

• Taltirelin Protects Dopaminergic Neurons in PD Models

  2026-07-07

  The reference study demonstrates that Taltirelin, a long-acting TRH analog, confers neuroprotection in both cellular and animal models of Parkinson’s disease by mitigating oxidative stress, apoptosis, and pathological protein cleavage. These findings advance Taltirelin as a promising candidate for disease-modifying intervention in neurodegenerative research.

• Metal-Ion-Chelating l-Phe Nanostructures Enhance ICB Respons

  2026-07-07

  This study introduces metal-ion-chelating l-phenylalanine nanostructures that, when combined with short-term starvation, remodel the immunosuppressive tumor microenvironment and significantly enhance the efficacy of immune checkpoint blockade in breast cancer. The research reveals mechanistic insights into dendritic cell activation via ion channel modulation, providing a foundation for improved cancer immunotherapy strategies.

• AMG 9810: Applied TRPV1 Antagonist Workflows in Pain Researc

  2026-07-06

  AMG 9810 empowers pain and sensory signaling research with nanomolar potency and high selectivity as a TRPV1 antagonist. This guide details optimized experimental workflows, troubleshooting strategies, and the translational impact of recent reference discoveries for precision data in neuronal assays.

15724 records 1/1049 page Next 12345 下5页 Last page